imagen laboratorio

Pipeline

SRB1 (hematologic tumors)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
SRB1 (solid tumors)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
Anti HER3-UND

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
Anti-HER3 mAb SRB17

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
Anti-HER3 – EGFR bispecific SRB19

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
Axencia Galega de Innovación